Effects of 6 months glucagon‐like peptide‐1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients

Hopkins, N. D.; Cuthbertson, D. J.; Kemp, G. J.; Pugh, C.; Green, D. J.; Cable, N. T.; Jones, H.

doi:10.1111/dom.12089

Effects of 6 months glucagon‐like peptide‐1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients

Glucagon‐like peptide‐1 receptor agonists ( GLP ‐1 RA ) are used for treatment in type 2 diabetes mellitus ( T2DM ). Little is known about their cardiovascular (CV) impact. We sought to determine the effects of chronic treatment on vascular function in T2DM . Brachial artery endothelial‐dependent…